View Post

Innovative Vaccine Technologies Are Disrupting Disease X

In COVID-19, Latest News by Precision Vaccinations

Vaccines are one of our most potent tools against infectious diseases, stated GAVI, the Vaccine Alliance.
Vaccines enabled the eradication of smallpox, and they have helped to reduce the number of polio cases by more than 99% since 1988, saving more than 13 million children from paralysis, add this editorial by Melanie Saville, Director, Coalition for Epidemic Preparedness Innovations (CEPI) published on February 11, 2021.
Excerpts from Saville’s editorial continue below.

View Post

What Causes Herpes Virus Flare-Ups?

In COVID-19, Latest News by Precision Vaccinations

University of Virginia (UVA) researchers have offered new insights on what causes herpes simplex virus (HSV-1) to flare up, explaining how stress, illness, and even sunburn can trigger unwanted outbreaks.
These researchers identified HSV-1 co-opts an innate immune pathway resulting from IL-1 stimulation of neurons to induce reactivation.
The discovery could lead to new ways to prevent cold sores and recurrent herpes-related eye disease from reoccurring, the researchers reported on February 11, 2021

View Post

What Causes Sudden Herpes Virus Outbreaks?

In COVID-19, Latest News by Precision Vaccinations

University of Virginia (UVA) researchers have offered new insights on what causes herpes simplex virus (HSV-1) to flare up, explaining how stress, illness, and even sunburn can trigger unwanted outbreaks.
These researchers identified HSV-1 co-opts an innate immune pathway resulting from IL-1 stimulation of neurons to induce reactivation.
The discovery could lead to new ways to prevent cold sores and recurrent herpes-related eye disease from reoccurring, the researchers reported on February 11, 2021

View Post

Rabies Immunoglobulin Treatment Found Safe and Effective

In COVID-19, Latest News by Precision Vaccinations

An existing rabies treatment, known as KEDRAB, was found by researchers to be safe and effective for patients age 17 and under.
Published in Human Vaccines & Immunotherapeutics on February 9, 2021, these researchers report the first and only pediatric trial of any human rabies immunoglobulin (HRIG) currently available in the USA.
According to the U.S. CDC, someone is treated for possible exposure to rabies every 10 minutes, and once clinical symptoms appear, rabies is virtually 100% fatal, said these researchers.